elecell
"elecell" secures seed funding from Synergy Partners
Known for its strong focus on the bio and medical sectors, Synergy Partners is one of the top venture capital firms in Korea. This investment is anticipated to boost elecell's company value and generate synergies in business development through Synergy Partners' extensive investment pool. elecell plans to use the funds from this investment to build a factory-level platform for generating AI drug candidates using AI supercomputing infrastructure. This platform will also support the development of launchpad services utilizing pre-identified drug candidates.
Let's talk .
Through this partnership, we can advance biomimetic current-based tissue regeneration and wound healing technologies and share groundbreaking solutions. Learn more about our partnership with Eleccell and join us as we strive to bring the world's first next-generation treatments to market.
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.
Let's talk .
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.